Hydroxy Urea-13C,15N2

• 产品号: H991002
• 分子式: CH4N2O2
• 分子量: 79.03413263
• 保 存: -20°C Freezer, Under Inert Atmosphere

产品别名

• 标题: Hydroxy Urea-13C,15N2
• IUPAC标准名: hydroxy(^1^3C,^1^5N₂)urea
• IUPAC传统名: hydroxy(^1^3C,^1^5N₂)urea
• 别名: SQ 1089-13C,15N2; Hydroxycarbamine-13C,15N2; Hydroxycarbamide-13C,15N2; Hydreia-13C,15N2; Droxia-13C,15N2; N-Hydroxyurea-13C,15N2; Carbamoyl Oxime-13C,15N2; Hydrea-13C,15N2; N-(Aminocarbonyl)hydroxylamine-13C,15N2; Hydura-13C,15N2; Litaler-13C,15N2; N-Carbamoylhydroxylamine-13C,15N2; NSC 32065-13C,15N2; Oxyurea-13C,15N2; SK 22591-13C,15N2; Biosupressin-13C,15N2; Carbamohydroxamic Acid-13C,15N2; Cytodrox-13C,15N2; Hydroxylurea-13C,15N2

产品性质

• 外观: Off-White Solid
• 熔点: 126-131°C (dec.)
• 溶解度: DMSO
• 保存条件: -20°C Freezer, Under Inert Atmosphere

产品详细信息

详细说明 (English)

Labelled Hydroxyurea. An anti-neoplastic - inhibits ribonucleoside reductase and DNA replication. A potential therapy for sickle cell anemia which involves the nitrosylation of sickle cell hemoglobin. Horseradish peroxidase catalyzes nitric oxide formatio

参考文献

• Ratcliffe, W., et al.: Lancet, 339, 164 (1992)
• Roodman, G., et al.: Cancer, 80, 1557 (1992)
• Horwitz, M., et al.: J. Clin. Endocrinol. Metab., 2003, 88, 1603 (1992)